Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
PT-141, also known as Bremelanotide, is a synthetic melanocortin receptor agonist derived from the α-MSH peptide sequence. It is currently under investigation in preclinical models for its role in central nervous system signaling, sexual motivation, and neuroendocrine modulation. Unlike compounds that act on vascular pathways, PT-141 engages MC3R and MC4R receptors in the brain, making it a focus of research into dopaminergic signaling, arousal behavior, and hypothalamic peptide interaction. This compound is provided strictly for laboratory research purposes and is not approved for human or veterinary use.
PT-141, also known as Bremelanotide, is a synthetic melanocortin receptor agonist derived from the α-MSH peptide sequence. It is currently under investigation in preclinical models for its role in central nervous system signaling, sexual motivation, and neuroendocrine modulation. Unlike compounds that act on vascular pathways, PT-141 engages MC3R and MC4R receptors in the brain, making it a focus of research into dopaminergic signaling, arousal behavior, and hypothalamic peptide interaction. This compound is provided strictly for laboratory research purposes and is not approved for human or veterinary use.